Open AccessPancreatic involvement in inflammatory bowel disease: a review
Author(s) -
Fotios S. Fousekis,
Vasileios Theopistos,
K.H. Katsanos,
D. K. Christodouloua
Publication year - 2019
Publication title -
vestnik kluba pankreatologov
Language(s) - English
Resource type - Journals
ISSN - 2077-5067
DOI - 10.33149/vkp.2019.03.02
Subject(s) - medicine , autoimmune pancreatitis , ulcerative colitis , inflammatory bowel disease , pancreatitis , gastroenterology , asymptomatic , pancreas , disease , acute pancreatitis , exocrine pancreatic insufficiency , population , environmental health
Inflammatory bowel disease (IBD) is a multisystemic disease, and pancreatic manifestations of IBD are not uncommon. The incidence of several pancreatic diseases in Crohn’s disease and ulcerative colitis is more frequent compared to the general population. Pancreatic manifestations in IBD include a wide heterogenic group of disorders and abnormalities of the pancreas and range from mild self-limited diseases to severe disorders. Acute pancreatitis, chronic pancreatitis, autoimmune pancreatitis, pancreatic autoantibodies, exocrine pancreatic insufficiency and asymptomatic imaging and laboratory abnormalities are included in related-IBD pancreatic manifestations. Involvement of the pancreas in IBD may be the result of IBD itself or of medications used.